Amsterdam Immunogenicity & Tolerance Seminar
Van derden
04/11/21 -
05/11/21
After a postponement due to COVID travel restrictions, EpiVax is pleased to announce new dates for this year’s Amsterdam Immunogenicity & Tolerance Seminar!
The seminar is now a two-day, afternoon-only format. This arrangement leaves mornings free for attendees to network, collaborate in small groups, and enjoy the beautiful city of Amsterdam.
All events will take place at the Hilton Apollolaan which is located at Apollolaan 138, 1077 BG, Amsterdam, Netherlands
Agenda
Day 1, Thursday, November 4th, 12:00 PM- 6 PM CET (Central European Time)
- Lunch will be provided from 12-1 PM
- Seminar talks will go from 1pm -6 PM
- Cocktail reception from 6 – 8 PM
Day 2, Friday November 5th, 1 PM – 5 PM CET (Central European Time)
- Lunch will provided from 12-1 PM
- Seminar talks will go from 1 PM – 5 PM
The seminar will focus on translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics. Confirmed speakers on the last both topics include:
Vaccines
Guilhem Richard, Ph.D. Lead Computational Immunologist, EpiVax Therapeutics
Corine Kruiswijk, Ph.D. Project Manager, Intravacc
Bram Slutter, Ph.D. Associate Professor, Leiden University
Willem van Eden, Ph.D. Professor Emeritus in Immunology, Utrecht University
Onur Özer, PhD Fellow, Max Planck Institute for Evolutionary Biology
Biologics
Naomi Benne, Ph.D. Postdoctoral Researcher, Utrecht University
Florian Deissenhammer, MD. Professor of Neurology, Medical University of Innsbruck
Amy Rosenberg , MD. Senior Director of Immunology and Protein Therapeutics, EpiVax
Interested in attending this free event? Register here!
